As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...
A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...
TUESDAY, Jan. 21, 2025 (HealthDay News) -- Black people with obesity are less likely to get weight-loss surgery than others.
The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will ...
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity for weight loss, doctors are observing a ...
The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...
People with hidden pockets of fat in their muscles – similar to so-called marbling in beef – are at a higher risk of dying from heart attacks or heart failure regardless of their body weight, ...